EFICACIA DE LA LINFADENECTOMIA
EXTENDIDA EN LA SOBREVIDA
BIBLIOGRAFÍA 1. Noguchi M, Miyazaqui I. Extended lymph node dissection in gastrointestinal cancer. J Surg Oncol 1997; 65 : 57 - 65. 2. Kampöschoer GHM, Maruyama K, van de Velde CJH, Sasako M, Kinosheta T, Okabayashi K. Computer analysis in making preoperative decision: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg 1989; 76 : 905 - 908. 3. Akoh JA, Macintyre IMC. Mejoría de la supervivencia en el cáncer gástrico: Revisión de las tasas de supervivencia a 5 años en publicaciones de lengua Inglesa desde 1970. Br J Surg (Ed. esp) 1992; 8 : 57 - 63. 4. Behrns KE, Dalton RR, van Heerden JA, Sarr MG. Extended lymph node dissection for gastric cancer. Is it of value - Surg Clin North Am 1992; 72 : 433 - 43. 5. Maruyama K, Gunver P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. Ann Surg 1989; 210 : 596 - 602. 6. Adachi Y, Kamakura T, Mori M, Maehara Y, Sugimachi K. Role of lymph node dissection and splenectomy in node - positive gastric carcinoma. Surgery 1994; 116: 837 - 41. 7. Secco GB, Fardelli R, Campora E, et al. Extension of lymph node dissection and survival in primary gastric cancer. Int Surg 1992; 77 : 242 -7. 8. Pacelli F, Doglieto G, Bellantone R, et al. Linfadenectomía ampliada o limitada en el cáncer gástrico : Estudio comparativo de 320 pacientes. Br J Surg 1993; 80: 1153- 56. 9. Volpe C, Koo J, Miloro S, Driscole D, Nava H, Douglas H. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma. J Am Coll Surg 1995; 181 : 56 - 64. 10. Smith J, Shiu M, Kelsey L, Bronnan MF. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg 1991; 126 : 1469 - 73. 11. Roder J, Bonenkamp J, Craven J, et al. Lymphadenectomy for gastric cancer in clinical trials : Update. World J Surg 1995; 19 : 546 - 53. 12. Korenaga D, Moriguchi S, Orita H, et al. Trends in survival rates in Japanese patients with advanced carcinoma of the stomach. Surg Gynecol Obstet 1992; 174 : 387 - 393. 13. Maruyama K, Sasako M, Kinoshita T, Okabayashi K. Reasonable lymph node disecction in radical gastrectomy for gastric cancer : Introduction of computer information system and lymphography technique by India-ink. Nippon Geka Gakkai Zasshi 1989; 90 : 1318 - 21. 14. Macintyre JMC, Akoh JA. Improving survival in gastric cancer: Review of operative mortality in English language publications from 1970. Br J Surg 1991; 78 : 773 - 8. 15. Christou NV. Evaluation of operative risk. In : Lindsey R (ed). Care of the surgical patient. 1st. Ed. New York : Scientific American; 1992. p. 15 - 30. 16. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11 : 418 - 25. 17. Díaz J, Tantaleán E, Urtecho A, Salinas E, Guzmán C. Cáncer de estómago resecable. Análisis de 134 casos consecutivos. Rev Gastroent Perú 1995; 15 : 265 - 72. 18. International Union Against Cancer. TNM - Classification of malignant tumors. En: Sobin LH, Wittekind Ch, Eds. Stomach. 5th. ed. New York : Willy - Liss; 1997. p. 59 - 62. 19. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. 1st. ed. Tokyo : Kanehara and Co; 1995. 20. Borrmann R. Gesch wulste des magens und duodenums. In : Honke F, Lubarsh O. Hanbuch der speziellen pathologischen anatomic und histologic. Berlin : J Springer; 1926. p. 812 - 1054. 21. Laurén P. The two histology main types of gastric carcinoma : Diffuse and so - called intestinal type carcinoma: An attempt at histo - clinical classification. Acta Pathol Microbial Scand 1965; 64: 31 - 49. 22. Jatzko G, Lisborg P, Klimpfinger M, Derit H. Extended radical surgery against gastric cancer: Low complications and high survival rates. Jpn J Clin Oncol 1992; 22: 102-106. 23. Robertson CS, Chunga SCS, Woods SDS, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994; 220: 176-182. 24. Noguchi Y, Imada T, Matsumoto A, Coit D, Brennan M. Radical surgery for gastric cancer. Cancer 1989; 64: 2053-2062. 25. Jatzko GR, Lisborg PH, Dent H, et al. A 10 - year experience with Japanese - type radical lymph node dissection for gastric cancer outside of Japan. Cancer 1995; 76: 1302 - 1312. 26. Parikh D, Johnson M, Chagla L, et al. D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg 1996; 83 : 1595 - 1599. 27. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJH. Extended lymph node dissection for gastric cancer. N Engl J Med 1999; 340: 908 - 14. 28. Cuschieri A, Fayers P, Fielding J, et al. Post-operative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996; 347: 995 -999. 29. Meyer HJ, Jahne J. Lymph node dissection for gastric cancer. Seminars in Surgical Oncology 1999; 17: 117 - 124. 30. Benavides C, Burmester R, Apablaza S. Linfadenectomía paraaórtica en cáncer gástrico. Rev Chilena de Cirugía 1994; 46: 491-496. 31. Wu CW, Hsich MC, Lo SS, et al. Morbidity and mortality after radical gastrectomy for patients with carcinoma of the stomach. J Am Coll Surg 1995; 181: 26-32. 32. Kinoshita T, Maruyama K, Sasako M, Okajima K. Treatment results of gastric cancer patients: Japanese experience. In: Nishi M, Ichikawa H, Nakajima T, eds. Gastric cancer. Tokyo: Springer-Verlag; 1993: 319-330. 33. Roe CF. Surgical aspects of fever. In: Hardy J. Problemas quirúrgicos graves. 2ª ed. Barcelona: Salvat Ed; 1985: 73-74. 34. Viste A, Haügstvedt T, Eide GE, et al. Postoperative complications and mortality after surgery for gastric cancer. Ann Surg 1988; 207: 7-12. 35. Cruce PJE, Food R. The epidemiology of wound infection: A 10-year prospective study of 62939 wounds. Surg Clin North Am 1980; 60: 27-40. 36. Díaz J, Tantaleán E, Calipuy W, Villacorta R, Sánchez L, Castañeda A. Microflora intragástrica endógena en cáncer de estómago. Rev Gastroent Perú 1998; 18: 227-237. 37. Ablan CJ, Littoy FN, Frecark RJ. Postoperative chylous ascites: Diagnosis and treatment. Arch Surg 1990; 125: 270-272. 38. Abasor IJ. Pancreatitis following of operations on the stomach. Arch Surg 1968; 96: 909. 39. Yamanaka H, Nishi M, Kanemaki T, et al. Preoperative nutritional assesment to predict postoperative complications in gastric cancer patients. JNEN 1989; 13: 286-291. 40. Noguchi M, Miyazaki I. Prognostic significance and surgical management of lymph node metastasis in gastric cancer (Review). Br J Surg 1996; 83: 156-61. 41. Bozzetti F, Regalici E, Bonfanti G, Doci R, Ballarini D, Gennari L. Early and late results of extended surgery for cancer of the stomach. Br J Surg 1990; 77:53-6. 42. Stipa S, di Giorgio A, Ferri M, Botti C. Results of curative gastrectomy for carcinoma. J Am Coll Surg 1994; 179: 567 - 72. 43. Arveux P, Faiore J, Boutron MC, Piard F, Dussurre - Guion L, Monnet E, et al. Prognosis of gastric carcinoma after curative surgery. A population based study using multivariate crude and relative survival analysis. Dig Dis Sci 1992; 37: 757 - 63. 44. Michelassi F, Takanishi DM Jr, Panlatone D, Hart J, Chapell R, Block GE. Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. Surgery 1994: 116: 804 - 10. 45. Maehara Y, Oshiro T, Oiwa H, Oda S, Baba H, Akazawa K, et al. Gastric carcinoma in patients over 70 years of age. Br J Surg 1995; 82: 102 - 105. 46. Maehara Y, Watanabe A, Kakeji Y, Emi Y, Moriguchi S, Anai H, et al. Prognosis for surgically treated gastric cancer patients is poorer for women than men in all patients under age 50. Br J Cancer 1992; 65: 417 - 20. 47. Sánchez-Bueno F, García-Marcilla JA, Pérez-Flores D, Pérez-Abad JM, Vicente R, Aranda F, Ramírez P, Parrilla P. Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg 1998; 85 : 255 - 60. 48. Salvon-Harman JC, Cady B, Nikulasson S, Khettry U, Stone MD, Lavin P. Shifting proportions of gastric adenocarcinomas. Arch Surg 1994; 129 : 381 -9. 49. Shiu MH, Perrotti M, Brennan MF. Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology 1989; 36 : 7 -12. 50. Calpena R, Medrano J, Del Fresno J, Canolela F, Vatquez J, Diego M, et al. Factores que influyen en la supervivencia de los pacientes diagnosticados de cáncer gástrico. Cirugía Española 1998; 43 : 560 -6. 51. Adachi Y, Kamatura T, Mori M, Baba H, Maehara Y, Sugimachi K. Prognostic significance of the number positive lymph nodes in gastric carcinoma. Br J Surg 1994; 81: 414-16. 52. Bollschweiller E, Boettcher K, Hoelscher AH, Sasako M, Kinoshita T, Maruyama K, et al. Is the prognosis for Japanase and German patients with gastric cancer really diferent -. Cancer 1993; 71: 2918-25. 53. Abe S, Shiraishi M, Nagoaka S, Yoshimura H, Dhar DK, Nakamura T. Serosal invasion as the single prognostic indicator in stage IIIA. (T3N1M0) gastric cancer. Surgery 1991; 109: 582-8. 54. Takagane A, Terashima M, Abe K, Araya M, Irinoda T, Yonezawa H, et al. Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer. Gastric Cancer 1999; 2:122-28. 55. Kwon SJ, Kim GS. Prognostic significance of lymph node metastasis in advanced carcinoma of the stomach. Br J Surg 1996; 83: 1600-03. 56. Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C. Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 1996; 83: 1604-7. 57. Shen KH. Factors correlated with number of metastatic lymph nodes in gastric cancer. Am J Gastroenterol 1999; 94: 104-8. 58. Maehara Y, Sakaguchi Y, Moriguchi S, et al. Signet ring cell carcinoma of the stomach. Cancer 1992; 69: 1645-50. 59. Csendes A, Medina E. Sobrevida de pacientes con cáncer gástrico III según tipo de resección. Rev Med Chile 1975; 103: 244-252. 60. Wu CW Hsich MJ, Lo SS, et al. Lymph node metastasis from carcinoma of the distal one-third of the stomach.Cancer 1994; 3: 2059-2064. 61. Sasako M. Risk factors for surgical treatment in the Ducht Gastric Cancer Trial. Br J Surg 1997; 84: 1567-71. 62. Inokuchi K. Prolonged survival of gastric cancer patients on a specific adjuvant chemotherapy. Jpn J Surg 1984; 4: 351-59. 63. Kodama J, Sugimachi K, Soejima K, et al. Evaluation of extensive lymph nodes disecction for carcinoma of the stomach. World J Surg 1981; 5: 241-48. 64. Okajima K, Isozaki H. Principles of surgical treatment . In: Gastric Cancer. Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E, eds. Tokio: Springer- Verlag; 1993.p. 280-91. 65. Bollschweiller E, Boettcher K, Hoelscher AH, et al. Valoración preoperatoria de las metástasis en los ganglios linfáticos en pacientes con cáncer gástrico: evaluación del programa informático Maruyama. Br J Surg 1992; 79: 156-60. |
